Dr. David Kessler, co-chair of President-elect Biden’s COVID task force, has been chosen to replace Dr. Moncef Slaoui as Chief Scientific Advisor to Operation Warp Speed, who has agreed to stay on a month to help Kessler with the transition. Dr. Kessler had resigned as President Clinton’s Food and Drug Administration Commissioner in late November 1996 after Clinton’s re-election following the controversy of his overbilling travel expenses during his tenure.
The National Legal and Policy Center (NLPC), an ethics watchdog group, which led the investigation into Kessler’s travel expenses when Kessler was FDA Commissioner, had called upon Biden in a November 18, 2020 press statement not to appoint Kessler as HHS Secretary, who was at that time a leading contender for the post. Instead, Biden chose Xavier Becerra as his HHS Secretary and this appointment appears to be a consolation prize. Notably, the critical position of the Commissioner … Read More ➡
Mega-firm BlackRock and CEO Larry Fink have called greater attention to ESG, beginning early in 2018 with a letter to more than 1,000 publicly traded companies urging them to elevate issues such as climate change and diversity higher in their considerations as they go about their business.
“Society is demanding that companies, both public and private, serve a social purpose,” he wrote. “To prosper over time, every company must not only deliver financial performance, but also show how it makes a positive contribution to society.”